Rankings
GLP-1 Provider Rankings
We have reviewed 325 providers and verified pricing for 26 of them. These pages turn that into rankings you can act on — every one with the caveat attached, because in this category every provider has one.
Best Online GLP-1 Providers
Our overall picks across 325 reviewed providers, with a category winner for value, format choice, insurance and clinical depth.
Read the ranking →Best Semaglutide Providers
Every provider whose semaglutide pricing we verified, cheapest first, plus what STEP 1 actually showed.
Read the ranking →Best Tirzepatide Providers
Verified tirzepatide pricing, why it costs more than semaglutide, and how to spot a microdose quote.
Read the ranking →Best Compounded GLP-1 Providers
If you are going the cash-pay compounded route, the cleanest records — and five questions to ask before paying.
Read the ranking →Cheapest GLP-1 Programs
Sorted by lowest verified price, with an honest account of what each cheap headline actually requires.
Read the ranking →Compare Every Provider
A single sortable view of all 325 providers we have reviewed, with ratings, badges and the one-line summary for each.
Read the ranking →All prices checked 7 August 2026. A provider appears in these rankings only where we verified the figures the ranking depends on against its own site. Providers carrying FDA warning letters, or whose marketing describes compounded medication as FDA-approved, are excluded from recommendation pages — their reviews remain on the site so you can read what we found.
Medical Disclaimer: This page is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting or changing any treatment. Compounded medications are not FDA-approved, are not evaluated by the FDA for safety, effectiveness or quality, and are not equivalent to the branded drug beyond sharing an active ingredient. GLP-1 medications commonly cause nausea, vomiting, diarrhoea and constipation, and carry risks including pancreatitis, gallbladder disease and kidney injury; they are contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2, and should not be used in pregnancy, when trying to conceive, or while breastfeeding. Prescribing is subject to clinician approval and is never guaranteed. Individual results vary and no outcome is promised.